Picture of SS Innovations International logo

SSII SS Innovations International Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapFalling Star

Momentum

Relative Strength (%)
1m-8.17%
3m+1.23%
6m+224.44%
1yr+150.23%
Volume Change (%)
10d/3m+295.73%
Price vs... (%)
52w High-56.11%
50d MA+1.3%
200d MA+64.13%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value141.53
Price to Tang. Book141.53
Price to Free Cashflown/a
Price to Sales92.24
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-90.13%
Return on Equity-115.45%
Operating Margin-91.9%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of SS Innovations International EPS forecast chart

Profile Summary

SS Innovations International, Inc. is a developer of surgical robotic technologies. The Company is developing a fully autonomous medical robotic system using software, which integrates artificial intelligence (AI) and deep learning, or machine learning (DL). Its product range includes its SSI Mantra surgical robotic system, and SSI Mudra is its range of surgical instruments capable of supporting a variety of surgical procedures, including robotic cardiac surgery. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset. The SSi Mantra is comprised of vision cart, which provides an additional 32-inch 3D 4K resolution monitor, identical to the surgeon’s console, for the operating room staff.

Directors

    Last Annual
    December 31st, 2024
    Last Interim
    December 31st, 2024
    Incorporated
    February 4th, 2015
    Public Since
    July 9th, 2018
    No. of Shareholders
    343
    No. of Employees
    378
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    us flag iconNASDAQ Capital Market
    Shares in Issue
    193,559,340

    SSII Share Price Performance

    Upcoming Events for SSII

    Q2 2025 SS Innovations International Inc Earnings Release

    Q3 2025 SS Innovations International Inc Earnings Release

    Similar to SSII

    Picture of ABVC Biopharma logo

    ABVC Biopharma

    us flag iconNASDAQ Capital Market

    Picture of Acesis Holdings logo

    Acesis Holdings

    us flag iconNASDAQ Capital Market

    Picture of Achieve Life Sciences logo

    Achieve Life Sciences

    us flag iconNASDAQ Capital Market

    Picture of Aclarion logo

    Aclarion

    us flag iconNASDAQ Capital Market

    Picture of Acurx Pharmaceuticals logo

    Acurx Pharmaceuticals

    us flag iconNASDAQ Capital Market

    FAQ